Periodic Reporting for period 1 - InnoTACA (Innovation Associate for highly specific Tumour Associated Carbohydrate Antigens)

Cancers such as colorectal cancer (CRC) have very poor standard of care and thus own an unmet need for reliable and specific target. CRC is a major cause of the cancer burden worldwide with approximately 1.4 million cases in 2012 and approximately 700,000 annual deaths...